US obesity rates may finally be falling, but weight-loss drugs are only part of the story

The Medical News ·
Health & Medicine United Kingdom

The 2026 JAMA Summit Report on Obesity examines the biological, socioeconomic, and environmental drivers of the global obesity epidemic, which now affects more than one billion people. The authors suggest that GLP-1 receptor agonists may already be contributing to declining US obesity prevalence, but lasting progress requires healthier food environments, equitable healthcare access, reduced…

Read original article on The Medical News →